tamsulosin has been researched along with Metabolic Syndrome in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akinsal, EC; Basar, H; Baydilli, N; Selvi, I; Tokmak, TT | 1 |
| Chapple, C; Gacci, M; Gemma, L; Gravas, S; Kaplan, SA; Liaci, A; Maggi, M; McVary, KT; Morselli, S; Sebastianelli, A; Serni, S; Spatafora, P; Vignozzi, L; Zaccaro, C | 1 |
| Cho, ST; Han, DH; Lee, YS; Yoon, H; Yoon, HS | 2 |
| Nieder, AM | 1 |
1 trial(s) available for tamsulosin and Metabolic Syndrome
| Article | Year |
|---|---|
Effect of Tamsulosin in Lower Urinary Tract Symptom Patients With Metabolic Syndrome.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Female; Humans; Lower Urinary Tract Symptoms; Male; Metabolic Syndrome; Middle Aged; Prospective Studies; Sulfonamides; Tamsulosin; Treatment Outcome | 2016 |
4 other study(ies) available for tamsulosin and Metabolic Syndrome
| Article | Year |
|---|---|
CT-related parameters and Framingham score as predictors of spontaneous passage of ureteral stones ≤ 10 mm: results from a prospective, observational, multicenter study.
Topics: Adult; Female; Follow-Up Studies; Heart Disease Risk Factors; Humans; Male; Metabolic Syndrome; Middle Aged; Prognosis; Prospective Studies; Reproducibility of Results; Severity of Illness Index; Tamsulosin; Tomography, X-Ray Computed; Treatment Outcome; Ureter; Ureteral Calculi; Urological Agents | 2021 |
Outcomes of combination therapy with daily tadalafil 5 mg plus tamsulosin 0.4 mg to treat lower urinary tract symptoms and erectile dysfunction in men with or without metabolic syndrome.
Topics: Double-Blind Method; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Metabolic Syndrome; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Quality of Life; Tadalafil; Tamsulosin | 2021 |
Editorial Comment.
Topics: Adrenergic alpha-1 Receptor Antagonists; Female; Humans; Lower Urinary Tract Symptoms; Male; Metabolic Syndrome; Sulfonamides; Tamsulosin | 2016 |
Author Reply.
Topics: Adrenergic alpha-1 Receptor Antagonists; Female; Humans; Lower Urinary Tract Symptoms; Male; Metabolic Syndrome; Sulfonamides; Tamsulosin | 2016 |